PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.
about
Procyanidins Negatively Affect the Activity of the Phosphatases of Regenerating LiverPhosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivoOverexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells.Phosphatase of regenerating liver: a novel target for cancer therapy.PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasionMembrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progressionCDH22 expression is reduced in metastatic melanoma.Tissue-specific alterations of PRL-1 and PRL-2 expression in cancerPRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness.Enzyme activity of phosphatase of regenerating liver is controlled by the redox environment and its C-terminal residues.Phosphatase of regenerating liver 2 (PRL2) deficiency impairs Kit signaling and spermatogenesis.Novel Anticancer Agents Based on Targeting the Trimer Interface of the PRL Phosphatase.Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase.Knockdown of proteolipid protein 2 or focal adhesion kinase with an artificial microRNA reduces growth and metastasis of B16BL6 melanoma cells.Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion
P2860
Q28546887-BF5B7AA0-B987-40DE-9C97-B508B92BC775Q33408806-515BD6A7-DB06-44EB-9A2C-D8711CC129A9Q33723723-E9AE271A-CC23-4945-9905-E9B91B245045Q34437541-71875596-D616-451E-BBA5-8A1AB375C74DQ34590459-4C4DF3D4-ED0E-4932-BDA1-2185E1B46937Q34731436-4362E1A7-D284-4E79-8B7D-E6D22731E3EEQ35145340-126D0A6A-114B-45B2-8674-EE52BBCFB0F2Q35232266-EB5B5905-2A25-4A25-8EF0-4C64C12209FFQ35747480-FA0D249F-B631-4B0D-8588-86D341F48A3DQ36977592-5C073665-EBC1-40A0-93A7-02E7F2FB3FC0Q37382038-567F5464-C18E-4E12-AD13-92A0EAE406F7Q37563586-ECFE759C-5820-4543-B7FB-B73EE8F0BE33Q38763126-D8F818B6-BBD5-4533-8AF1-1CCE80D8B1FBQ39782575-1612F7E1-0814-4F7E-AFB1-4D47685DA2C4Q42176841-2591886C-DA29-4CAA-9970-2A470CD8BC56Q48103763-9763749A-C097-4ED5-886B-46DFFD2C305EQ56375935-84F98F64-E99B-46CE-ABEA-3B97384571A5
P2860
PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.
@ast
PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.
@en
type
label
PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.
@ast
PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.
@en
prefLabel
PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.
@ast
PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.
@en
P2093
P2860
P356
P1433
P1476
PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.
@en
P2093
Shao-Xian Cao
Zi-Chao Zhang
Zi-Chun Hua
P2860
P2888
P304
P356
10.2119/2006-00076.QIAN
P407
P577
2007-03-01T00:00:00Z
P6179
1068964964